These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6821923)

  • 1. Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Clin Chem; 1983 Feb; 29(2):225-36. PubMed ID: 6821923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
    Aiach M; Léon M; Michaud A; Capron L
    Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.
    Friberger P
    Semin Thromb Hemost; 1983 Oct; 9(4):281-300. PubMed ID: 6362011
    [No Abstract]   [Full Text] [Related]  

  • 4. Automated instrumentation and the laboratory diagnosis of bleeding and thrombotic disorders.
    Walenga J; Fareed J; Bermes EW
    Semin Thromb Hemost; 1983 Jul; 9(3):172-93. PubMed ID: 6351253
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid determination of five coagulation parameters in one sample with a centrifugal analyzer.
    Bas BM; Costongs GM; Janson PC
    Haemostasis; 1987; 17(5):260-7. PubMed ID: 3478286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood clotting diagnosis with chromogenic substrates].
    Róka L; Rasche H
    Internist (Berl); 1980 Apr; 21(4):189-94. PubMed ID: 6998907
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements.
    Fareed J; Messmore HL; Walenga JM; Bermes EW; Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):288-301. PubMed ID: 6817417
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of a centrifugal analyzer in coagulation testing.
    Hills LP; Lorenzi-Anderson M; Huey EE; Tiffany TO
    Semin Thromb Hemost; 1983 Jul; 9(3):217-27. PubMed ID: 6612352
    [No Abstract]   [Full Text] [Related]  

  • 11. Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) method.
    Nowak-Göttl U; Funk M; Mosch G; Wegerich B; Kornhuber B; Breddin HK
    Klin Padiatr; 1994; 206(6):437-9. PubMed ID: 7529848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III and plasminogen: a comparison of two synthetic substrate-based methods.
    Ito RK; Statland BE
    Am J Clin Pathol; 1983 Oct; 80(4):465-73. PubMed ID: 6624709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic substrate assays of the coagulation enzymes and their inhibitors. Comparison with clotting and immunologic methods for clinical and experimental usage.
    Messmore HL; Fareed J; Kniffin J; Squillaci G; Walenga J
    Ann N Y Acad Sci; 1981; 370():785-97. PubMed ID: 7023331
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.
    Rodzynek JJ; Urbain D; Leautaud P; Wettendorff P; Delcourt A
    Gut; 1984 Oct; 25(10):1050-6. PubMed ID: 6479679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; new synthetic chromogenic substrate assays for hemostatic parameters].
    Hiura H; Nishiyama T; Kimura M; Matoba K; Hayashi O; Sasaki M; Ishijima C; Irie Y; Yasuda N
    Rinsho Byori; 1989 Apr; Spec No 81():214-9. PubMed ID: 2754808
    [No Abstract]   [Full Text] [Related]  

  • 16. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
    Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
    Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
    [No Abstract]   [Full Text] [Related]  

  • 17. New perspectives in coagulation testing.
    Fareed J; Messmore HL; Bermes EW
    Clin Chem; 1980 Sep; 26(10):1380-91. PubMed ID: 6996867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monitoring anticoagulant treatment with the KEM-O-MAT 2HP autoanalyzer].
    Laharrague P; Leleu T; Poignot JL; Cambus JP; Biermé R
    Nouv Rev Fr Hematol (1978); 1983; 25(2):107-12. PubMed ID: 6866753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood coagulation-fibrinolysis tests by a biochemical method].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1993 Jul; 41(7):743-9. PubMed ID: 8361043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of automation in the development of reagents and kits for automated methods in coagulation testing.
    Martinoli JL; Amiral J
    Semin Thromb Hemost; 1983 Jul; 9(3):194-205. PubMed ID: 6351254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.